Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GB-0669 in Healthy Adult Participants
Clinical trial NCT07050511 · COMPLETED
Trial details
- NCT number
- NCT07050511
- Sponsor
- Generate Biomedicines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-18
- Primary completion
- 2024-11-22
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.